Thema: INE044A01036
Sun Pharma, INE044A01036
wealth-69525_1920.jpg - Foto: THN
Crisil rates Sun Pharma debt AAA. Sun Pharma stock is valued at INR 4.2 trillion
The board approved an INR 100.0 billion debt plan on October 12, 2026. Sun Pharma stock saw Q1 fiscal 2027 revenue reach INR 153.00 billion.
ad-hoc-news.de, heute 11:11 Uhr
Sun Pharma, INE044A01036
Analyst consensus puts Sun Pharma stock at INR 2,180.00
Fiscal 2026 sales reached INR 584.60 billion. Sun Pharma stock costs INR 1,764.00 on October 15, 2026, up 1.01 percent on NSE.
ad-hoc-news.de, 15.10.26 15:14 Uhr
Sun Pharma, INE044A01036
Sun Pharma approves INR 100.0 billion plan: Sun Pharma stock ...
First-quarter fiscal 2027 revenue rose 4.71 percent to INR 153.00 billion. Sun Pharma stock is valued at INR 4.2 trillion on October 15, 2026.
ad-hoc-news.de, 15.10.26 11:05 Uhr
Sun Pharma, INE044A01036
Sun Pharma grows revenue 10.50 percent: Sun Pharma stock ...
Margin reached 28.10 percent in first-quarter fiscal 2027. Sun Pharma stock costs INR 1,746.40 on October 14, 2026, down 1.37 percent on NSE.
ad-hoc-news.de, 14.10.26 13:37 Uhr
Sun Pharma, INE044A01036
Geojit raises target for Sun Pharma stock to INR 2 070.00 ...
Q1 fiscal 2027 revenue rose 10.50 percent to INR 153.00 billion. Sun Pharma stock stood at INR 1,770.70 on October 13, 2026, up 0.61 percent on NSE.
ad-hoc-news.de, 13.10.26 13:07 Uhr
Sun Pharma, INE044A01036
Sun Pharma approves INR 100.00 billion debt issue: what ...
Board approved INR 100.00 billion debentures on October 12, 2026. For Sun Pharma stock, Q1 fiscal 2027 revenue rose 10.10 percent to INR 153.0 billion.
ad-hoc-news.de, 13.10.26 10:31 Uhr
Sun Pharma, INE044A01036
Sun Pharma stock at INR 1 760.00 14.0 percent below high ...
Sun Pharma stock was last at INR 1,760.00 on October 9, 2026. It stood 14.00 percent below the INR 2,046.90 high, with a P/E of 34.91.
ad-hoc-news.de, 12.10.26 13:14 Uhr
Sun Pharma, INE044A01036
Sun Pharma planned INR 150 billion debt issue: what it means ...
Sun Pharma stock faces an INR 150.00 billion debt proposal dated October 7, 2026. Q1 fiscal 2027 revenue rose 10.10 percent to INR 153.00 billion.
ad-hoc-news.de, 12.10.26 10:47 Uhr
Sun Pharma, INE044A01036
Sun Pharma stock trades at INR 1 760.00 14.0 percent below ...
Q1 fiscal 2027 revenue hit INR 153.0 billion, up 10.10 percent. Sun Pharma stock costs INR 1,760.00 on October 9, 2026 after INR 1,759.80.
ad-hoc-news.de, 09.10.26 15:32 Uhr
Sun Pharma, INE044A01036
Sun Pharma plans INR 150 billion debt issue: what it means ...
